MALFACINI, Davide
 Distribuzione geografica
Continente #
NA - Nord America 4.443
AS - Asia 1.844
EU - Europa 1.404
SA - Sud America 279
Continente sconosciuto - Info sul continente non disponibili 101
AF - Africa 40
OC - Oceania 6
Totale 8.117
Nazione #
US - Stati Uniti d'America 4.323
SG - Singapore 608
CN - Cina 454
IT - Italia 386
VN - Vietnam 251
DE - Germania 237
BR - Brasile 218
PL - Polonia 170
HK - Hong Kong 133
FI - Finlandia 125
GB - Regno Unito 116
BD - Bangladesh 109
UA - Ucraina 97
TR - Turchia 87
CA - Canada 68
SE - Svezia 67
FR - Francia 61
JP - Giappone 52
RU - Federazione Russa 44
IN - India 35
MX - Messico 31
ID - Indonesia 30
NL - Olanda 30
AR - Argentina 23
BE - Belgio 17
PK - Pakistan 14
IQ - Iraq 12
ZA - Sudafrica 11
ES - Italia 10
LT - Lituania 10
EC - Ecuador 9
IE - Irlanda 9
TN - Tunisia 9
MY - Malesia 8
UZ - Uzbekistan 8
VE - Venezuela 8
MA - Marocco 7
CO - Colombia 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
CZ - Repubblica Ceca 5
AU - Australia 4
JM - Giamaica 4
KR - Corea 4
NP - Nepal 4
PH - Filippine 4
RO - Romania 4
AZ - Azerbaigian 3
BO - Bolivia 3
CL - Cile 3
DO - Repubblica Dominicana 3
EG - Egitto 3
EU - Europa 3
NG - Nigeria 3
PE - Perù 3
PR - Porto Rico 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CH - Svizzera 2
IR - Iran 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TH - Thailandia 1
TV - Tuvalu 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 8.019
Città #
Dallas 814
Ashburn 521
Singapore 379
San Jose 279
Fairfield 264
Woodbridge 232
Ann Arbor 192
Warsaw 168
Beijing 158
Houston 151
Chandler 142
Santa Clara 139
Seattle 137
Munich 129
Hong Kong 122
Wilmington 119
Jacksonville 115
Council Bluffs 107
Ferrara 103
New York 96
Cambridge 92
Helsinki 79
Los Angeles 74
Ho Chi Minh City 72
Hanoi 50
Tokyo 50
Izmir 43
Milan 41
Nanjing 40
Dong Ket 34
Lauterbourg 31
Princeton 28
Shanghai 27
Bologna 26
São Paulo 26
The Dalles 25
Boardman 23
Dearborn 20
Jakarta 19
Toronto 19
Chicago 18
Phoenix 18
Brussels 17
Mexico City 17
Brooklyn 16
Buffalo 16
Fuzhou 15
Mcallen 14
Montreal 14
San Diego 14
Montréal 13
Padova 13
Amsterdam 12
Frankfurt am Main 12
Moscow 12
Turku 12
Atlanta 11
Da Nang 11
London 11
Denver 10
Haiphong 10
Nanchang 10
Orem 10
Rio de Janeiro 10
Stockholm 10
Boston 9
Dublin 9
Hefei 9
Poplar 9
Rome 9
Columbus 8
Florence 8
Lahore 8
Tashkent 8
Chennai 7
Falls Church 7
Bremen 6
Changsha 6
Dhaka 6
Jiaxing 6
Johannesburg 6
Nuremberg 6
Auburn Hills 5
Baghdad 5
Brasília 5
Jyväskylä 5
Kuala Lumpur 5
Lappeenranta 5
Manchester 5
Mumbai 5
Naples 5
Padua 5
Philadelphia 5
San Francisco 5
Shenyang 5
Tianjin 5
Addison 4
Ankara 4
Augusta 4
Bari 4
Totale 5.725
Nome #
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 998
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 382
Novel ligands and assays for nociceptin/orphanin FQ and classical opioid receptors 381
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 310
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 297
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 271
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 256
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 240
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 234
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 233
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 221
Pharmacological characterization of tachykinin tetrabranched derivatives 221
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 219
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 213
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 210
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 208
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 207
null 205
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 196
NOP receptor pharmacological profile – A dynamic mass redistribution study 187
Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues 184
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 184
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 180
Pharmacological Assays for Investigating the NOP Receptor 179
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 158
In vitro and in vivo study of butyrylfentanyl and 4‐fluorobutyrylfentanyl in female and male mice: Role of the CRF1 receptor in cardiorespiratory impairment 153
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 148
A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study 147
Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study 144
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop 122
Pharmacological characterization of naloxegol: In vitro and in vivo studies 118
null 110
null 105
null 103
Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity 98
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 89
null 78
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 71
Rational design of a heterotrimeric G protein subunit with artificial inhibitor sensitivity 36
Comprehensive transduceromic profiling of NOP receptor ligands at different Gα subunits 21
Totale 8.117
Categoria #
all - tutte 30.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.021
Totale 31.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022241 0 19 2 12 21 21 16 25 17 32 15 61
2022/2023317 32 31 17 42 43 40 17 34 31 3 14 13
2023/2024288 18 23 5 7 14 58 14 57 3 9 17 63
2024/20251.048 29 39 80 32 91 123 80 70 172 89 138 105
2025/20263.736 317 286 819 362 395 217 344 173 240 301 152 130
2026/2027248 114 134 0 0 0 0 0 0 0 0 0 0
Totale 8.117